181 related articles for article (PubMed ID: 30872752)
1. Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis.
Hsu HM; Chu CM; Chang YJ; Yu JC; Chen CT; Jian CE; Lee CY; Chiang YT; Chang CW; Chang YT
Sci Rep; 2019 Mar; 9(1):4484. PubMed ID: 30872752
[TBL] [Abstract][Full Text] [Related]
2. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
3. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer.
Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM
Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117
[TBL] [Abstract][Full Text] [Related]
4. Identification of tRNA-derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple-negative breast cancer.
Feng W; Li Y; Chu J; Li J; Zhang Y; Ding X; Fu Z; Li W; Huang X; Yin Y
Cancer Med; 2018 Oct; 7(10):5130-5144. PubMed ID: 30239174
[TBL] [Abstract][Full Text] [Related]
5. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
Naorem LD; Muthaiyan M; Venkatesan A
J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification of triple-negative breast cancer with core gene signatures associated with chemoresponse and prognosis.
Kim EK; Park AK; Ko E; Park WY; Lee KM; Noh DY; Han W
Breast Cancer Res Treat; 2019 Nov; 178(1):185-197. PubMed ID: 31342312
[TBL] [Abstract][Full Text] [Related]
7. Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.
Suo HD; Tao Z; Zhang L; Jin ZN; Li XY; Ma W; Wang Z; Qiu Y; Jin F; Chen B; Cao Y
Biomed Res Int; 2020; 2020():7575862. PubMed ID: 32766313
[TBL] [Abstract][Full Text] [Related]
8. Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study.
Yoshikawa K; Ishida M; Yanai H; Tsuta K; Sekimoto M; Sugie T
PLoS One; 2020; 15(11):e0242563. PubMed ID: 33201923
[TBL] [Abstract][Full Text] [Related]
9. Screening and identification of potential biomarkers in triple-negative breast cancer by integrated analysis.
Guo J; Gong G; Zhang B
Oncol Rep; 2017 Oct; 38(4):2219-2228. PubMed ID: 28849078
[TBL] [Abstract][Full Text] [Related]
10. Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel.
Lim GB; Kim YA; Seo JH; Lee HJ; Gong G; Park SH
BMC Cancer; 2020 Nov; 20(1):1052. PubMed ID: 33138797
[TBL] [Abstract][Full Text] [Related]
11. Gene expression in triple-negative breast cancer in relation to survival.
Wang S; Beeghly-Fadiel A; Cai Q; Cai H; Guo X; Shi L; Wu J; Ye F; Qiu Q; Zheng Y; Zheng W; Bao PP; Shu XO
Breast Cancer Res Treat; 2018 Aug; 171(1):199-207. PubMed ID: 29748761
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series.
Picornell AC; Echavarria I; Alvarez E; López-Tarruella S; Jerez Y; Hoadley K; Parker JS; Del Monte-Millán M; Ramos-Medina R; Gayarre J; Ocaña I; Cebollero M; Massarrah T; Moreno F; García Saenz JA; Gómez Moreno H; Ballesteros A; Ruiz Borrego M; Perou CM; Martin M
BMC Genomics; 2019 Jun; 20(1):452. PubMed ID: 31159741
[TBL] [Abstract][Full Text] [Related]
13. Novel key genes in triple-negative breast cancer identified by weighted gene co-expression network analysis.
Chen J; Qian X; He Y; Han X; Pan Y
J Cell Biochem; 2019 Oct; 120(10):16900-16912. PubMed ID: 31081967
[TBL] [Abstract][Full Text] [Related]
14. A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.
Park YH; Jung HH; Do IG; Cho EY; Sohn I; Jung SH; Kil WH; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH
Int J Cancer; 2015 Apr; 136(8):1976-84. PubMed ID: 25537444
[TBL] [Abstract][Full Text] [Related]
15. Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer.
Chou CW; Huang YM; Chang YJ; Huang CY; Hung CS
Int J Med Sci; 2021; 18(12):2521-2531. PubMed ID: 34104083
[TBL] [Abstract][Full Text] [Related]
16. Gene regulatory pattern analysis reveals essential role of core transcriptional factors' activation in triple-negative breast cancer.
Min L; Zhang C; Qu L; Huang J; Jiang L; Liu J; Pinello L; Yuan GC; Shou C
Oncotarget; 2017 Mar; 8(13):21938-21953. PubMed ID: 28423538
[TBL] [Abstract][Full Text] [Related]
17. Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer.
Zhou Q; Ren J; Hou J; Wang G; Ju L; Xiao Y; Gong Y
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2383-2396. PubMed ID: 31280346
[TBL] [Abstract][Full Text] [Related]
18. Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis.
Wushou A; Jiang YZ; Hou J; Liu YR; Guo XM; Shao ZM
Breast Cancer Res Treat; 2015 Nov; 154(1):57-62. PubMed ID: 26476726
[TBL] [Abstract][Full Text] [Related]
19. Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
Boac BM; Abbasi F; Ismail-Khan R; Xiong Y; Siddique A; Park H; Han M; Saeed-Vafa D; Soliman H; Henry B; Pena MJ; McClung EC; Robertson SE; Todd SL; Lopez A; Sun W; Apuri S; Lancaster JM; Berglund AE; Magliocco AM; Marchion DC
Sci Rep; 2019 Nov; 9(1):17496. PubMed ID: 31767884
[TBL] [Abstract][Full Text] [Related]
20. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.
Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
Front Immunol; 2021; 12():749459. PubMed ID: 34603338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]